Interleukin-15 as an Immune Adjuvant To Increase the Efficacy of Mycobacterium bovis Bacillus Calmette-Guérin Vaccination
Interleukin-15 (IL-15) transgenic mice which had been inoculated with Mycobacterium bovis bacillus Calmette-Guérin (BCG) 24 weeks previously showed resistance against airborne infection with Mycobacterium tuberculosis H37Rv accompanied by an increased CD8(+)-Tc1-cell response. IL-15 may be used as a...
Spremljeno u:
| Izdano u: | Infect Immun |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
2003
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC201060/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14500526/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.71.10.6045-6048.2003 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
